Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency

Int J Obes Relat Metab Disord. 1997 Jan;21(1):27-32. doi: 10.1038/sj.ijo.0800356.

Abstract

Objective: To evaluate the maximal secretory capacity of somatotrope cells in obesity and to compare it with that in hypopituitaric patients with GH deficiency.

Design: Stimulation with GHRH. (1 microgram/kg i.v.), combined with arginine (ARG, 0.5 g/kg i.v.), which strongly potentiates the GH response to the neurohormone, likely inhibiting hypothalamic somatostatin. The reproducibility of the GH response to GHRH + ARG was evaluated in a second session.

Subjects: Forty-five patients with simple obesity (OB 11 male and 34 female, age 40.5 +/- 1.8 y, BMI 38.8 +/- 1.1 kg/m2), 49 patients with hypopituitarism (GHD, 23 male and 26 female, 43.6 +/- 2.4 y, 24.7 +/- 0.7 kg/m2) and 44 normal young volunteers (NS, 25 male and 19 female, 33.8 +/- 1.0 y, 21.6 +/- 0.3 kg/m2) were studied.

Measurements: GH levels were assayed by IRMA method, basally at -60 and 0 min, and than every 15 min up to +120 min. Basal IGF-I levels were assayed by RIA method, after acid-ethanol extraction.

Results: IGF-I levels in OB were lower (P < 0.005) than those in NS but higher (P < 0.005) than those in GHD. Mean peak GH response to GHRH + ARG in OB was clearly lower than that in NS (P < 0.005) and higher (P < 0.005) than that in GHD. Sixty-percent OB and 100% GHD showed peak GH responses lower than the minimum normal limit in NS (16.5 micrograms/l) while 4% OB and only 53% GHD with GH responses lower than 3 micrograms/l, the limit under which GH replacement therapy of severe deficiency is allowed. Good intraindividual reproducibility of the GH response to GHRH + arginine test was present in all groups (OB: r = 0.78, P < 0.0001; GHD: r = 0.57, P < 0.003; NS: r = 0.74, P < 0.0001;.

Conclusions: The maximal secretory capacity of somatotrope cells is clearly less than normal in the obese but still more than is seen in GHD subjects. However, in about 50% of obese patients, the pituitary GH releasable pool overlaps with that of hypopituitaric patients with GH deficiency. Thus, even when the maximal secretory capacity of somatotrope cells is evaluated by a potent and reproducible provocative tests such as GHRH + arginine, overweight has to be taken in a great account as the cause of severely impaired GH response in patients with suspected GH deficiency.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arginine / pharmacology
  • Female
  • Growth Hormone-Releasing Hormone / pharmacology
  • Human Growth Hormone / blood
  • Human Growth Hormone / drug effects
  • Human Growth Hormone / metabolism*
  • Humans
  • Hypopituitarism / blood*
  • Hypopituitarism / metabolism
  • Male
  • Middle Aged
  • Obesity / blood*
  • Obesity / metabolism
  • Reproducibility of Results
  • Time Factors

Substances

  • Human Growth Hormone
  • Growth Hormone-Releasing Hormone
  • Arginine